test

Wajih Zaheer MD, FACP

Asstt Clinical Professor Of Medicine (Medical Oncology)

Clinical Interests

solid tumor malignancies, particularly breast, lung, and gastrointestinal cancers/pancreatic cancer ; hematologic malignancies such as lymphoma, leukemia, and myeloproliferative disorders. Genitourinary malignancies.


Board Certifications

1991
Internal Medicine, Board Certified
1996
Hematology, Internal Medicine, Board Certified
1995
Medical Oncology, Board Certified

Patient Care Locations

wajih_zaheerfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Colorectal Cancer and ColonA Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer (CALGB 80702)
Non Small Cell Lung Cancer, Lung Cancer, and LungA Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) (CIRB) (SWOG S0819)
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's LymphomaA Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Cancer, Breast - Female, and Breast - MalePhase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer (S1207)
PancreasPhase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer

More Clinical Trials...

Edit Profile